Biohaven announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application for Vyglxia, an experimental treatment for spinocerebellar ataxia, a rare inherited neurodegenerative disease. This acceptance signals renewed regulatory review and optimism for the drug's approval, which has driven Biohaven's stock to its best performance in three years. The FDA's review process will determine if Vyglxia can become a new treatment option for patients suffering from this debilitating condition.
Biohaven's FDA resubmission news provides context for health sector trading on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 22, 2026 23:11 WIB: Out of 150 health-sector US stocks, 92 rose and 56 fell. Notable movers include NVAX at USD 10.38 with a 1-day change of -5.68% and 99% sell order activity, ILMN at USD 267.27 with a 1-day change of -5.51% and 68% buy order activity, and TWST at USD 141.12 with a 1-day change of -5.37% and 93% buy order activity.
Remittix is set to add 41 new fiat currencies to its PayFi ecosystem, enhancing crypto-to-bank and bank-to-crypto transactions globally ahead of its November 24 RTX launch. This expansion aims to support more international markets and users, includin...
First Pacific Bancorp announced solid third quarter 2026 results, with total assets reaching $532 million, up $42 million from year-end 2025. Deposits increased to $449 million, and loans grew to $362 million, reflecting steady balance sheet expansio...
ICEYE and Nokia have signed a Letter of Intent with Ukraine's Ministry of Defence to collaborate on building sovereign satellite communication capabilities. This partnership aims to enhance Ukraine's defense by providing secure, high-performance sate...
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
